Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohan Bhavane

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Current Drug Targets|October 16, 2014
Multistage Nanovectors Enhance the Delivery of Free and Encapsulated DrugsJonathan O Martinez, Michael Evangelopoulos, Rohan Bhavane, et al.
Nanotechnology|October 24, 2022
Hybrid, dual visible and near-infrared fluorescence emission of (6,5) single-walled carbon nanotubes modified with fluorescein through aryl diazonium salt chemistryMateusz Michał Tomczyk, Masafumi Minoshima, Kazuya Kikuchi, et al.
Journal of Biomedical Materials Research. Part A|August 10, 2010
Tailoring the degradation kinetics of mesoporous silicon structures through PEGylationBiana Godin, Jianhua Gu, Rita E Serda, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Feasibility Study of Ferumoxtyol for Contrast-enhanced MRI of Retroplacental Clear Space Disruption in Placenta Accreta Spectrum (PAS)Andrew A Badachhape, Brian Burnett, Prajwal Bhandari, et al.
Scientific Reports|June 15, 2016
A liposomal Gd contrast agent does not cross the mouse placental barrierAnil N Shetty, Robia Pautler, Ketan Ghaghada, et al.
Scientific Reports|February 17, 2017
Corrigendum: A liposomal Gd contrast agent does not cross the mouse placental barrierAnil N Shetty, Robia Pautler, Ketan Ghaghada, et al.
Circulation. Cardiovascular Imaging|January 26, 2013
Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agentRohan Bhavane, Cristian Badea, Ketan B Ghaghada, et al.
Theranostics|August 1, 2022
A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imagingParag Parekh, Qingshan Mu, Andrew Badachhape, et al.
Nature Nanotechnology|July 26, 2008
Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applicationsEnnio Tasciotti, Xuewu Liu, Rohan Bhavane, et al.
Placenta|January 9, 2025
Ferumoxytol-enhanced MRI of retroplacental clear space disruption in placenta accreta spectrumAndrew A Badachhape, Brian Burnett, Prajwal Bhandari, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Current Drug Targets|October 16, 2014
Multistage Nanovectors Enhance the Delivery of Free and Encapsulated DrugsJonathan O Martinez, Michael Evangelopoulos, Rohan Bhavane, et al.
Nanotechnology|October 24, 2022
Hybrid, dual visible and near-infrared fluorescence emission of (6,5) single-walled carbon nanotubes modified with fluorescein through aryl diazonium salt chemistryMateusz Michał Tomczyk, Masafumi Minoshima, Kazuya Kikuchi, et al.
Journal of Biomedical Materials Research. Part A|August 10, 2010
Tailoring the degradation kinetics of mesoporous silicon structures through PEGylationBiana Godin, Jianhua Gu, Rita E Serda, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Feasibility Study of Ferumoxtyol for Contrast-enhanced MRI of Retroplacental Clear Space Disruption in Placenta Accreta Spectrum (PAS)Andrew A Badachhape, Brian Burnett, Prajwal Bhandari, et al.
Scientific Reports|June 15, 2016
A liposomal Gd contrast agent does not cross the mouse placental barrierAnil N Shetty, Robia Pautler, Ketan Ghaghada, et al.
Scientific Reports|February 17, 2017
Corrigendum: A liposomal Gd contrast agent does not cross the mouse placental barrierAnil N Shetty, Robia Pautler, Ketan Ghaghada, et al.
Circulation. Cardiovascular Imaging|January 26, 2013
Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agentRohan Bhavane, Cristian Badea, Ketan B Ghaghada, et al.
Theranostics|August 1, 2022
A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imagingParag Parekh, Qingshan Mu, Andrew Badachhape, et al.
Nature Nanotechnology|July 26, 2008
Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applicationsEnnio Tasciotti, Xuewu Liu, Rohan Bhavane, et al.
Placenta|January 9, 2025
Ferumoxytol-enhanced MRI of retroplacental clear space disruption in placenta accreta spectrumAndrew A Badachhape, Brian Burnett, Prajwal Bhandari, et al.
Pageof 3